Analgesia and anesthesia for the ill or injured dog and cat

Description

Content: Intro Title Page Copyright Page Contents List of Contributors Preface Acknowledgements Chapter 1 General Considerations for Pain Management upon Initial Presentation and during Hospital Stay References Further Reading Chapter 2 Physiology and Pathophysiology of Pain I. Pain versus Nociception II. The Pain Pathway in Physiologic Pain A. Transduction B. Transmission C. Modulation D. Perception E. Endogenous Analgesic Pathways III. The Pain Pathway in Pathologic Pain A. Transduction B. Transmission C. Modulation D. Perception E. Descending Inhibitory Pathway IV. Specific Types of PainA. Neonatal/Pediatric Pain B. Neuropathic Pain C. Visceral Pain D. Breakthrough Pain E. Stimulus-Evoked/Movement-Evoked Pain References Further Reading Chapter 3 Physiologic and Pharmacologic Applications to Manage Neuropathic Pain I. Physiology of Neuropathic Pain A. The Patient's Experience B. The Quality and Pattern of Altered Sensitivity C. Immune Response Mechanisms in Neuropathic Pain D. Endogenous Descending Facilitatory Systems [8] E. Descending Inhibitory Pathway [9] F. To Summarize Neuropathic Pain II. Clinical Relevance of Physiology to PharmacologyA. Opioids/Opiates B. Tricyclic Antidepressant Analgesic (TCA) Effects C. Gabapentin D. NMDA Receptor Antagonists E. Local Anesthetics F. Alpha2 Adrenergic (Alpha2) Agonists G. Nonsteroidal Anti-Inflammatory Analgesics (NSAIAs) H. Acupuncture III. Diagnosing Neuropathic Pain IV. Neuropathic Pain Associated Conditions A. Neuropathic Pain Associated with Trauma: Accidental and Surgical B. Lumbosacral Lesions C. Spinal Cord Injury D. Potential Sources of Neck and Back Pain in Cats and Dogs V. Primary Lesions of the Peripheral or central Nervous SystemA. Peripheral Nervous System B. Central Pain Syndrome VI. Neuropathic Pain and Management of Visceral Origin VII. Treatment A. Acute Pain Management B. Chronic Neuropathic Pain Management VIII. Future Therapeutic Modalities A. Vanilloid Receptor 1 Antagonists B. Serotonin and Norepinephrine Re‐Uptake Inhibitor Mixed Compound IX. Conclusion References Further Reading Chapter 4 Physiology and Pharmacology: Clinical Application to Abdominal and Pelvic Visceral Pain I. Neurophysiology Reviews [1-3] A. Afferent and Efferent InnervationsB. Autonomic Nervous System [4] C. Central Processing [2] D. Peripheral Sensitization E. Central Sensitization (Inflammation-Induced) II. Clinical Relevance of Physiology to Pharmacology A. Dorsal Horn Targets for Analgesics [3] B. Peripheral Sensitization Targets for Analgesics C. Reduction/Modulation of the Transmission of Nociceptive Information D. Epidural Site for Analgesic Administration III. Sources of Abdominal Pain A. Gastrointestinal System B. Urogenital System IV. Pelvis and Perineum [3, 5] A. Pelvis